FDA Device Intelligence
Home › PEAR THERAPEUTICS, INC. › reSET® Introductory Access Limited Version (Mobile App, iOS)

reSET® Introductory Access Limited Version (Mobile App, iOS)

PEAR THERAPEUTICS, INC. · Model 1 · UDI-DI 10851580008149

PWE Prescription
1
510(k) clearances
2
Adverse events (1 deaths)
2
Recalls
1
Facilities

Description

reSET® Mobile Application running on iOS. reSET is a prescription-only digital therapy intended to deliver cognitive behavioral therapy (CBT) to patients with substance use disorder (SUD). The Introductory Access Limited Version provides limited access to the reSET product.

Recalls

DateFirmReason
2021-06-07Pear Therapeutics, Inc.Due to a software issue, patients with a urine drug screen (UDS) received access to a contingency management wheel spin for potential rewards regardless of the UDS results. Positi
2021-06-07Pear Therapeutics, Inc.Due to a software issue, patients with a urine drug screen (UDS) received access to a contingency management wheel spin for potential rewards regardless of the UDS results. Positi

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.